ENO2 and neoplasm: Positive staining for neuroendocrine markers (NSE, synaptophysin, chromogranin A) and negative staining for lymphoid (CD3, Pax5) and nephroblastoma (WT1) markers were pivotal in confirming the tumor’s neuroendocrine origin.